GlassScriptPhysician profile
Maria Gonzalez
NPI 1356323810
$4,613.74
in general payments reported to CMS, 2019-2025
20 companies · $716 in 2025
The $716 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $566 · 2021: $841 · 2022: $644 · 2023: $373 · 2024: $440 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385 · Entertainment: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.00 |
| Entertainment | $144.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,120.54 | 2020-2025 | Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $679.58 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $411.65 | 2022-2025 | Miebo, Infuse, Xiidra |
| Optos, INC. | $304.96 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $273.96 | 2019-2020 | |
| Shire North American Group INC | $264.68 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $203.49 | 2019-2021 | |
| Sight Sciences, INC. | $162.33 | 2021-2022 | |
| Allergan, INC. | $139.69 | 2019-2021 | |
| Visioneering Technologies, INC. | $139.65 | 2019 | |
| Abbvie INC. | $132.19 | 2022-2023 | |
| Maculogix, INC. | $129.36 | 2020 | |
| Topcon Healthcare, INC. | $121.96 | 2020 | |
| Sun Pharmaceutical Industries INC. | $118.43 | 2020 | |
| Horizon Therapeutics Plc | $117.76 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $114.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $71.28 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Rxsight INC | $38.46 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.